###begin article-title 0
###xml 135 140 <span type="species:ncbi:9606">human</span>
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries
###end article-title 0
###begin p 1
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 1134 1135 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1169 1170 1160 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1188 1189 1179 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1214 1215 1205 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1293 1297 1284 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 1352 1356 1343 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 1388 1392 1379 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 1408 1414 1399 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 1444 1450 1435 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-2</italic>
###xml 1469 1473 1460 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 1625 1629 1616 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 853 861 <span type="species:ncbi:9606">patients</span>
###xml 1109 1114 <span type="species:ncbi:9606">human</span>
###xml 1228 1233 <span type="species:ncbi:9606">human</span>
Several studies have demonstrated an association between polycystic ovary syndrome (PCOS) and the dinucleotide repeat microsatellite marker D19S884, which is located in intron 55 of the fibrillin-3 (FBN3) gene. Fibrillins, including FBN1 and 2, interact with latent transforming growth factor (TGF)-beta-binding proteins (LTBP) and thereby control the bioactivity of TGFbetas. TGFbetas stimulate fibroblast replication and collagen production. The PCOS ovarian phenotype includes increased stromal collagen and expansion of the ovarian cortex, features feasibly influenced by abnormal fibrillin expression. To examine a possible role of fibrillins in PCOS, particularly FBN3, we undertook tagging and functional single nucleotide polymorphism (SNP) analysis (32 SNPs including 10 that generate non-synonymous amino acid changes) using DNA from 173 PCOS patients and 194 controls. No SNP showed a significant association with PCOS and alleles of most SNPs showed almost identical population frequencies between PCOS and control subjects. No significant differences were observed for microsatellite D19S884. In human PCO stroma/cortex (n = 4) and non-PCO ovarian stroma (n = 9), follicles (n = 3) and corpora lutea (n = 3) and in human ovarian cancer cell lines (KGN, SKOV-3, OVCAR-3, OVCAR-5), FBN1 mRNA levels were approximately 100 times greater than FBN2 and 200-1000-fold greater than FBN3. Expression of LTBP-1 mRNA was 3-fold greater than LTBP-2. We conclude that FBN3 appears to have little involvement in PCOS but cannot rule out that other markers in the region of chromosome 19p13.2 are associated with PCOS or that FBN3 expression occurs in other organs and that this may be influencing the PCOS phenotype.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 232 257 232 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C28">Knochenhauer <italic>et al</italic>., 1998</xref>
###xml 279 284 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 259 291 259 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C11">Diamanti-Kandarakis <italic>et al</italic>., 1999</xref>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 425 444 425 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C9">Conway <italic>et al</italic>., 1989</xref>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 446 464 446 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C3">Balen <italic>et al</italic>., 1995</xref>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 527 544 527 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C53">Wild <italic>et al</italic>., 1985</xref>
###xml 546 572 546 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C52">Wild and Bartholomew, 1988</xref>
###xml 595 600 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 574 607 574 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C40">Slowinska-Srzednicka <italic>et al</italic>., 1991</xref>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 609 626 609 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C54">Wild <italic>et al</italic>., 1992</xref>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 628 648 628 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C41">Talbott <italic>et al</italic>., 1995</xref>
###xml 685 690 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 672 697 672 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C28">Knochenhauer <italic>et al</italic>., 1998</xref>
###xml 719 724 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 699 731 699 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C11">Diamanti-Kandarakis <italic>et al</italic>., 1999</xref>
###xml 897 920 897 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C2">Amato and Simpson, 2004</xref>
###xml 1053 1058 1053 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1047 1065 1047 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C30">Legro <italic>et al</italic>., 2002</xref>
###xml 1074 1079 1074 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1067 1086 1067 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C55">Yildiz <italic>et al</italic>., 2003</xref>
###xml 1227 1232 1227 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1219 1239 1219 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>
###xml 98 103 <span type="species:ncbi:9606">women</span>
###xml 321 326 <span type="species:ncbi:9606">women</span>
###xml 1142 1147 <span type="species:ncbi:9606">women</span>
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects an estimated 5-7% of women of reproductive age in western societies and is characterized by hyperandrogenemia, chronic anovulation and polycystic ovaries (Knochenhauer et al., 1998; Diamanti-Kandarakis et al., 1999). Hirsuitism is common among women who suffer from the disorder, and they are at increased risk of anovulatory infertility, obesity (Conway et al., 1989; Balen et al., 1995), hyperlipidaemia and predisposing factors for heart disease (Wild et al., 1985; Wild and Bartholomew, 1988; Slowinska-Srzednicka et al., 1991; Wild et al., 1992; Talbott et al., 1995) and type II diabetes (Knochenhauer et al., 1998; Diamanti-Kandarakis et al., 1999). While the aetiology of PCOS is unknown, familial studies have demonstrated heritability of the disorder, suggesting that there is a genetic component (reviewed in Amato and Simpson, 2004). Female first-degree relatives display strong association between the metabolic abnormalities of PCOS and hyperandrogenemia (Legro et al., 2002; Yildiz et al., 2003), and a recent study demonstrated that the brothers of women with PCOS also have a strong association with metabolic abnormalities (Urbanek et al., 2007). This suggests a common genetic association between the metabolic features of PCOS and hyperandrogenemia, whether that be a defect in the same gene or multiple genes in the same pathway.
###end p 3
###begin p 4
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 227 245 227 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C7">Carey <italic>et al</italic>., 1994</xref>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 247 267 247 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C15">Gharani <italic>et al</italic>., 1997</xref>
###xml 319 331 319 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C13">Franks, 1995</xref>
###xml 742 746 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 788 793 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 782 800 782 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>
###xml 813 818 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 802 825 802 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C49">Villuendas <italic>et al</italic>., 2003</xref>
###xml 835 840 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 827 847 827 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C46">Urbanek <italic>et al</italic>., 2005</xref>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 849 869 849 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>
###xml 905 909 905 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 989 993 989 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 1058 1062 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 1206 1210 1206 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 555 562 <span type="species:ncbi:9606">patient</span>
The mode of inheritance of PCOS has proven difficult to determine suggesting that the disorder is a complex trait possibly involving multiple genes and/or environmental influences. Many genes in the steroid synthesis pathways (Carey et al., 1994; Gharani et al., 1997), the regulatory pathways of gonadotrophin action (Franks, 1995) and the insulin-signalling pathway have been investigated for association with the disorder. Many of these studies, however, have proven inconclusive or are not reproducible. In contrast, several studies using independent patient cohorts have demonstrated a significant association between PCOS and the dinucleotide repeat microsatellite marker D19S884, which is located 1cM upstream of the insulin receptor (INSR) gene in chromosome region19p13.2 (Tucci et al., 2001; Villuendas et al., 2003; Urbanek et al., 2005; Urbanek et al., 2007). The distance of this marker from INSR casts doubt upon the likelihood of there being a causal genetic variant within INSR and it is more probable that variant(s) in a distal enhancer of INSR or an unrelated gene are the reason for the association between D19S884 and PCOS. D19S884 is located within intron 55 of the fibrillin-3 gene (FBN3).
###end p 4
###begin p 5
###xml 278 285 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1, 2</italic>
###xml 290 291 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 299 304 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 293 311 290 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C39">Sakai <italic>et al</italic>., 1986</xref>
###xml 317 322 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 313 329 310 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C29">Lee <italic>et al</italic>., 1991</xref>
###xml 338 343 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 331 350 328 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C10">Corson <italic>et al</italic>., 2004</xref>
###xml 374 386 371 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP 1, 2, 3</italic>
###xml 391 392 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 402 407 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 394 414 391 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C25">Kanzaki <italic>et al</italic>., 1990</xref>
###xml 422 427 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 416 434 413 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C34">Moren <italic>et al</italic>., 1994</xref>
###xml 440 445 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 436 452 433 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C56">Yin <italic>et al</italic>., 1995</xref>
###xml 461 466 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 454 473 451 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C17">Giltay <italic>et al</italic>., 1997</xref>
###xml 529 533 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 595 600 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 588 607 585 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C10">Corson <italic>et al</italic>., 2004</xref>
###xml 610 614 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 746 751 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 738 758 735 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C51">Wheeler <italic>et al</italic>., 2003</xref>
###xml 767 772 764 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 760 779 757 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C10">Corson <italic>et al</italic>., 2004</xref>
###xml 793 797 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 802 803 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 1148 1173 1136 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C38">Ramirez and Pereira, 1999</xref>
###xml 1182 1187 1170 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1175 1194 1163 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C27">Kielty <italic>et al</italic>., 2002</xref>
###xml 1204 1209 1192 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1196 1216 1184 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C35">Neptune <italic>et al</italic>., 2003</xref>
###xml 1338 1343 1323 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1331 1350 1316 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C16">Gibson <italic>et al</italic>., 1995</xref>
###xml 1412 1417 1397 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1405 1424 1390 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C21">Hirani <italic>et al</italic>., 2007</xref>
###xml 1512 1517 1494 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1503 1524 1485 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C33">Miyazono <italic>et al</italic>., 1991</xref>
###xml 1866 1870 1845 1849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 1936 1941 1912 1917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1928 1948 1904 1924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C5">Boileau <italic>et al</italic>., 2005</xref>
###xml 1979 1983 1955 1959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 643 648 <span type="species:ncbi:9606">human</span>
###xml 671 676 <span type="species:ncbi:9606">human</span>
Fibrillins and latent TGF-beta-binding proteins (LTBPs) form a family of proteins that are characterized by a modular domain structure comprising epidermal growth factor-like (EGF) domains, calcium-binding EGF domains and unique cysteine-rich TB domains. Three fibrillin genes, FBN1, 2 and 3 (Sakai et al., 1986; Lee et al., 1991; Corson et al., 2004), and four LTBP genes, LTBP 1, 2, 3 and 4 (Kanzaki et al., 1990; Moren et al., 1994; Yin et al., 1995; Giltay et al., 1997), have been identified in mammals, although in rodents FBN3 has been disrupted due to chromosomal rearrangements (Corson et al., 2004). FBN3 is most highly expressed in human fetal tissues and the human adult brain, eye, lung, adrenal glands, stomach and ovaries (Wheeler et al., 2003; Corson et al., 2004). Studies of FBN1 and 2 have shown that they function as structural components of elastin fibres or mircrofibrils and as regulators of TGF-beta family members. Regulation of TGF-beta activity by the fibrillins is a result of their ability to bind to LTBPs causing sequestration of latent TGF-betas into the extracellular matrix where they are stored and/or activated (Ramirez and Pereira, 1999; Kielty et al., 2002; Neptune et al., 2003). However, there are subtle differences between them. For instance, LTBP-2 itself does not bind latent TGF-betas (Gibson et al., 1995), but can competitively replace LTBP-1 bound to FBN1 (Hirani et al., 2007). LTBPs are also required for the correct secretion and folding of TGF-betas (Miyazono et al., 1991). To date, interactions between FBN3 and LTBPs have not been investigated. Clinical consequences of the disruption of the interaction between the fibrillins and TGF-betas have been reported previously in the pathogenesis of Marfan's syndrome, a connective tissue disorder affecting the limbs, the heart, the lungs and the eyes. Mutations in FBN1 or the TGF-beta type 2 receptor cause Marfan's syndrome (Boileau et al., 2005). The ability of mutations in FBN1 to phenocopy those in TGF-betaR type 2 suggests that the structural role of FBN1 in the formation of elastic fibres and microfibrils is less critical to the pathology of the disease than its role in regulating the bioavailability of TGF-beta family members.
###end p 5
###begin p 6
###xml 118 123 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 110 130 107 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C18">Glister <italic>et al</italic>., 2005</xref>
###xml 132 136 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C19">2006</xref>
###xml 333 338 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 325 345 322 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C44">Urbanek <italic>et al</italic>., 1999</xref>
###xml 355 360 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 347 367 344 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C45">Urbanek <italic>et al</italic>., 2000</xref>
###xml 378 383 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 369 390 366 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C26">Kevenaar <italic>et al</italic>., 2008</xref>
###xml 581 586 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 572 593 569 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C42">Thompson <italic>et al</italic>., 2005</xref>
###xml 725 730 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 717 737 714 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C45">Urbanek <italic>et al</italic>., 2000</xref>
###xml 745 750 742 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 739 757 736 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C24">Jones <italic>et al</italic>., 2007</xref>
###xml 768 773 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 759 780 756 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C26">Kevenaar <italic>et al</italic>., 2008</xref>
###xml 1014 1029 1011 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C22">Hughesdon, 1982</xref>
###xml 1265 1290 1256 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C20">Govinden and Bhoola, 2003</xref>
###xml 1297 1302 1288 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1292 1309 1283 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C50">Wang <italic>et al</italic>., 2003</xref>
###xml 1320 1325 1311 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1311 1332 1302 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C58">Zeisberg <italic>et al</italic>., 2003</xref>
###xml 1334 1362 1325 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C48">Verrecchia and Mauviel, 2004</xref>
###xml 1364 1390 1355 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C8">Christner and Ayitey, 2006</xref>
###xml 1837 1841 1825 1829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 1960 1964 1948 1952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 783 788 <span type="species:ncbi:9606">Women</span>
###xml 2100 2105 <span type="species:ncbi:9606">human</span>
The involvement of the TGF-beta superfamily in the development of PCOS has been implied from functional data (Glister et al., 2005, 2006) and the association of several members, including anti-Mullerian hormone (AMH), activin, inhibin and their associated receptors, as well as follistatin, and the SMADS, has been examined (Urbanek et al., 1999; Urbanek et al., 2000; Kevenaar et al., 2008). Strong association of these genes with PCOS has not been demonstrated, however, it has been suggested that both follistatin, which like fibrillins and LTBPs, contain a TB domain (Thompson et al., 2005), and AMH may contribute to the severity of the PCOS phenotype by influencing androgen levels and/or follicle development (Urbanek et al., 2000; Jones et al., 2007; Kevenaar et al., 2008). Women with PCOS not only display aberrant follicle maturation, but also develop a thickening of the tunica albuginea and stromal tissues of their ovaries that is associated with an increase of collagen deposition in these regions (Hughesdon, 1982). TGF-beta superfamily members have been implicated in the regulation of collagen synthesis by fibroblasts in fibroses; TGF-beta promotes collagen expression and fibrosis while bone morphogenic protein (BMP)7 suppresses these effects (Govinden and Bhoola, 2003; Wang et al., 2003; Zeisberg et al., 2003; Verrecchia and Mauviel, 2004; Christner and Ayitey, 2006). Hence we have considered the possibility that the fibrillin/LTBP protein family members may be involved in both the gross ovarian morphological and follicular developmental defects associated with PCOS through a disruption in fibrillin-LTBP interactions resulting in perturbations in TGF-beta signalling pathways. For these reasons, we chose to undertake a case-control PCOS association test of 32 single nucleotide polymorphisms (SNPs) within FBN3. We included non-synonymous SNPs located in the coding region of the gene with the aim of identifying PCOS-associated FBN3 variants that may lead to disrupted protein function. We also examined the RNA expression profiles of fibrillin/LTBP family members in human ovarian tissues and cell lines.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
Subjects for DNA genotyping
###end title 8
###begin p 9
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 390 408 390 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C32">Milner <italic>et al</italic>. 1999</xref>
###xml 667 692 667 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C57">Zawadski and Dunaif, 1992</xref>
###xml 895 900 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 889 907 889 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C1">Adams <italic>et al</italic>., 1986</xref>
###xml 1327 1332 1327 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1320 1339 1320 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C32">Milner <italic>et al</italic>., 1999</xref>
###xml 76 81 <span type="species:ncbi:9606">Human</span>
###xml 439 444 <span type="species:ncbi:9606">women</span>
###xml 559 564 <span type="species:ncbi:9606">women</span>
###xml 925 930 <span type="species:ncbi:9606">women</span>
###xml 1000 1005 <span type="species:ncbi:9606">women</span>
###xml 1052 1060 <span type="species:ncbi:9606">patients</span>
###xml 1227 1235 <span type="species:ncbi:9606">patients</span>
Ethics approval for this study was obtained from the University of Adelaide Human Research Ethics Committee. Case subjects were recruited from infertility and antenatal clinics at The Queen Elizabeth Hospital in Adelaide, South Australia, after approval by the ethics committee of North Western Adelaide Health Services. Details of a number of these subjects have been reported previously (Milner et al. 1999). The study group represented women of various European cultural backgrounds who generally can be classified as Caucasian. Case subjects consisted of women with PCOS defined as hyperandrogenism and chronic anovulation as per the 1990 NIH consensus criteria (Zawadski and Dunaif, 1992). Polycystic ovaries were identified on ultrasound and defined as the presence of at least eight peripheral cysts less than 10 mm in diameter, with increased ovarian stroma occurring bilaterally (Adams et al., 1986). A total of 367 women between the ages of 18 and 42 were recruited and of these, 173 (47%) women fulfilled the criteria for PCOS. A further 86 patients from the same clinics but who had none of the characteristics of PCOS, and largely male-factor related reasons for infertility, served as controls. An additional 108 patients whose PCO status was unknown were recruited from the female blood donor population (Milner et al., 1999). All samples were de-identified for further analysis.
###end p 9
###begin title 10
DNA extraction
###end title 10
###begin p 11
Peripheral blood lymphocytes were purified from whole blood using Lymphoprep (Nycomed Pharma, Oslo, Norway) and kept frozen in saline at -20degreesC until DNA extraction. DNA was extracted from this tissue using a DNeasy Kit (QIAGEN, Chatsworth, CA) as per the manufacturer's protocol, quantified by spectrophotometry and stored at -20degreesC.
###end p 11
###begin title 12
Analyses of SNPs
###end title 12
###begin p 13
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 301 323 301 323 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.hapmap.org/">http://www.hapmap.org/</uri>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 434 435 434 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 640 671 640 671 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/snp">http://www.ncbi.nlm.nih.gov/snp</uri>
###xml 825 848 825 848 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://snpper.chip.org/">http://snpper.chip.org/</uri>
###xml 949 977 949 977 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</uri>
###xml 1011 1035 1011 1035 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="https://www.realsnp.com/">https://www.realsnp.com/</uri>
###xml 1428 1431 1415 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1522 1523 1505 1506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2455 2460 2398 2403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2450 2467 2393 2410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C59">Zhao <italic>et al</italic>., 2006</xref>
We typed a single multiplex of 32 tagging and functional SNPs spanning an 82 kb region of FBN3. Tagging SNPs (a set of SNPs that through high linkage disequilibrium (LD) capture the variation in other common SNPs in the region) were chosen using genotyping data from the International HapMap Project (http://www.hapmap.org/) from a population of Caucasian and European background (CEU), having minor allelic frequencies of >0.05 and r2 values of >0.8. Additional functional SNPs that produce a change in protein sequence were chosen to complete the multiplex using genotyping data from the SNP database at the National Library of Medicine (http://www.ncbi.nlm.nih.gov/snp), such that they would not interfere with the multiplexing of the tagging SNPs. All SNP sequences were downloaded from the Chip Bioinformatics database (http://snpper.chip.org/) and the sequences were cross checked with the National Center for Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov/) and Sequenom RealSNP databases (https://www.realsnp.com/) before assay design. Assays were designed for the 32 SNPs using the Sequenom MassARRAY Assay Design software (version 3.1). SNPs were typed using iPLEX trade mark Gold chemistry and analysed using a Sequenom MassARRAY Compact Mass Spectrometer (Sequenom Inc, San Diego, CA, USA). The 2.5 microL PCR reactions were performed in standard 384-well plates using 12.5 ng genomic DNA, 0.8 unit of Taq polymerase (HotStarTaq, Qiagen, Valencia, CA), 500 micromol of each dNTP, 1.625 mM of MgCl2 and 100 nmol of each PCR primer (Bioneer, Daejeon, Korea). PCR thermal cycling in an ABI-9700 instrument was 15 min at 94degreesC, followed by 45 cycles of 20 s at 94degreesC, 30 s at 56degreesC and 60 s at 72degreesC. To the completed PCR reaction, 0.15 U shrimp alkaline phosphatase was added and incubated for 40 min at 37degreesC followed by inactivation for 5 min at 85degreesC. A mixture of extension primers was tested to adjust the concentrations of extension primers to equilibrate signal-to-noise ratios in the matrix-assisted laser desorption/ionization - time of flight (MALDI-TOF) mass spectrometry prior to use for extension reactions. The post-PCR reactions were performed in a final 5 microl of extension reaction containing 1x termination mix, 1 U DNA polymerase and 570- 1240 nM extension primers. A two-step 200 short cycle programme was used for the iPLEX Gold reaction as described in a previously study (Zhao et al., 2006). The iPLEX reaction products were desalted by diluting samples with 15 microl of water and adding 5 microl of resin (Sequenom Inc, San Diego, CA, USA). The products were spotted on a SpectroChip (Sequenom Inc), and data were processed and analysed by MassARRAY TYPER 3.4 software (Sequenom Inc).
###end p 13
###begin title 14
Microsatellite genotyping
###end title 14
###begin p 15
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB1">I</xref>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB1">I</xref>
###xml 423 426 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 492 493 492 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 326 331 <span type="species:ncbi:9606">human</span>
To detect microsatellite D19S884 alleles we designed our own primers (Table I) rather than using those suggested for amplimer AFMa299zc5 listed in Genbank as we found these to be unreliable. Primers were designed using Primer Express software (Applied Biosystems, Foster City, CA, USA), from the published genomic sequence of human FBN3 (Table I). The amplification reactions were performed using 50 ng genomic DNA, 1 U of Taq polymerase (AmpliTaq Gold, PE Applied Biosystems) in 1.56 mM MgCl2, 0.1 mM of each dNTP and 10 nmol of each primer. The cycling conditions were 95degreesC initially for 7 min followed by 40 cycles of 95degreesC, 55degreesC and 72degreesC of 30 s each, then a final extension of 30 min at 72degreesC. The fluorescent PCR products were assayed by capillary electrophoresis and visually analysed using the ABI 3730 DNA Analyser (Applied Biosystems) with GeneScan Analysis software. Allele lengths were confirmed by DNA sequencing of homozygous alleles.
###end p 15
###begin p 16
Primers used for qRT-PCR and microsatellite genotyping
###end p 16
###begin title 17
Statistical analyses
###end title 17
###begin p 18
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 90 134 90 134 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.broad.mit.edu/haploview/haploview">http://www.broad.mit.edu/haploview/haploview</uri>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 137 157 137 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C4">Barrett <italic>et al</italic>., 2005</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 304 324 304 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C6">Buchner <italic>et al</italic>., 1997</xref>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 619 634 619 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C12">Dudbridge, 2008</xref>
###xml 773 774 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 954 1001 954 1001 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="www.mds.qmw.ac.uk/statgen/dcurtis/software.html">www.mds.qmw.ac.uk/statgen/dcurtis/software.html</uri>
###xml 1028 1029 1028 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1162 1178 1162 1178 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="www.graphpad.com">www.graphpad.com</uri>
LD analyses and pairwise LD plots of D' were generated using the Haploview 3.32 software (http://www.broad.mit.edu/haploview/haploview) (Barrett et al., 2005). The statistical power to detect an association in our case-control cohort was calculated by post-hoc tests implemented in the G.Power software (Buchner et al., 1997) for an alpha (P-value) of 0.05 over effect sizes ranging from 0.1 (small) to 0.5 (medium). The sample has 60% power to detect an effect size of 0.2 and greater than 88% power for effect sizes of 0.3 or more. Case-control association tests for SNP markers were performed using unphased 3.0.10 (Dudbridge, 2008). Odds ratios (ORs) with corresponding 95% confidence intervals (95% CI) were calculated using Woolf's formula with Haldane's correction. P-values were corrected for multiple comparisons using Bonferroni's correction. Case-control association tests for the microsatellite marker D19S884 were performed using Clump 2.3 (www.mds.qmw.ac.uk/statgen/dcurtis/software.html) and Fisher's exact test. P-values for Fisher's exact tests were calculated using GraphPad Prism 5.00 for Windows (GraphPad Software, San Diego California USA, www.graphpad.com) and were Bonferroni corrected for multiple comparisons.
###end p 18
###begin title 19
Tissues for gene expression analyses
###end title 19
###begin p 20
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 667 685 667 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C31">Mason <italic>et al</italic>., 1994</xref>
###xml 740 741 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 803 804 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 845 846 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1070 1075 1070 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1064 1082 1064 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C36">Nishi <italic>et al</italic>., 2001</xref>
###xml 361 366 <span type="species:ncbi:9606">women</span>
###xml 857 862 <span type="species:ncbi:9606">human</span>
Collection of tissues for gene expression analyses was approved by the Institution Review Boards of the University of Texas Southwestern Medical Center, Dallas, USA, St Georges University of London, England and The University of Adelaide, Australia. Informed written consent was obtained prior to collection of tissues. Tissues were obtained from premenopausal women undergoing procedures for benign gynaecologic conditions. PCOS ovarian phenotype was diagnosed based on the presence of three or more of the following criteria: enlarged ovarian volume (>9 ml), 10 or more follicles of 2-8 mm in diameter, increased density and volume of stroma or a thickened tunica (Mason et al., 1994). Specimens were obtained from ovarian stroma/cortex (n = 9 non-PCO and 4 PCO ovarian phenotype), ovarian follicles (n = 3, >8 mm diameter) and corpora lutea (n = 3). The human ovarian cancer cell lines OVCAR-3, OVCAR-5 and SKOV-3 (ascites derived) originating from ovarian adenocarcinomas were obtained from the ATCC (Manassas, VA, USA) and the granulosa tumour cell line KGN (Nishi et al., 2001) was obtained with consent from its originators Professors Hajime Nawata and Toshihiko Yanase of Kyushu University and Professor Yoshihiro Nishi of Kurume University. Tissues and cells were either stored in RNAlater (Ambion, Inc., Austin, TX) at -20degreesC, or snap frozen in liquid nitrogen and stored at -80degreesC prior to RNA or protein isolation.
###end p 20
###begin title 21
Gene expression analyses
###end title 21
###begin p 22
###xml 800 807 784 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1, 2</italic>
###xml 812 813 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 819 825 803 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 830 832 814 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-2</italic>
###xml 857 858 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB1">I</xref>
###xml 794 799 <span type="species:ncbi:9606">human</span>
Total RNA was isolated from approximately100 mg wet weight of stored stromal tissue using 1 ml of Trizol (Invitrogen Australia Pty. Ltd., Mt Waverley, VIC, Australia). Briefly, tissue was homogenized for approximately 30 s on ice using a polytron homogenizer before extraction was carried out as per manufacturer's instructions. Ten micrograms of total RNA was treated with 2 U of DNase I (Ambion Inc, Austin, TX, USA) and first-strand complementary DNA (cDNA) was synthesized from the DNase-treated RNA (2.5 microg) using 200 U Superscript III reverse transcriptase (Invitrogen Australia Pty. Ltd.) and 500 ng random hexamers (Geneworks, Thebarton, SA, Australia). Primers were designed against published mRNA sequences using Primer Express software (Applied Biosystems). Primer sequences for human FBN1, 2 and 3 and, LTBP-1 and -2 mRNA are shown in Table I. Real-time PCR amplification was performed using an ABI PRISM 7000 sequence detection system (Applied Biosystems) by adding 2.5 microl of appropriately diluted cDNA, 10 microl 2x SYBR green master mix (Applied Biosystems), 7.1 microl water and 0.2 microl of 12.5 microM forward and reverse primers per well. Samples were amplified in duplicate for one cycle at 50degreesC for 2 min and 95degreesC for 10 min, followed by 40 cycles of 95degreesC for 15 s and 60degreesC for 1 min.
###end p 22
###begin p 23
###xml 622 623 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 623 624 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 739 740 737 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 740 741 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 856 857 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 857 858 855 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1186 1194 1184 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
To generate a standard curve for each PCR assay, DNA standards for each target sequence were prepared by sub-cloning the PCR products of the corresponding target sequence into pCR2.1-TOPO vector (Invitrogen). The plasmid DNA was isolated and quantified using a Nanodrop spectrophotometer (Nanodrop technologies, Wilmington, DE, USA). DNA sequences were verified by automated sequencing (3730 DNA analyser, Applied Biosystems). Concentrations were calculated from absorbance at 260 nm. Plasmid DNA was serially diluted over three logs to establish a standard curve in a range, determined for each sample, which bounded the CT values obtained for samples (between 1 ng/mul and 10 ag/mul). Concentration of each target was generated from the CT and standard curve and was normalized to the concentration of 18S ribosomal RNA in each sample (calculated by the CT and standard curve for 18S). Gene expression of target sequences was subsequently expressed as fmoles target sequence mRNA/nmole 18S ribosomal RNA. For each gene the expression levels were normally distributed and comparisons between each ovarian compartment and between PCO and non-PCO tissues were compared by ANOVA, with no post hoc tests necessary as no significant differences were found.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
SNP and microsatellite analyses
###end title 25
###begin title 26
Marker selection
###end title 26
###begin p 27
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB2">II</xref>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F1">1</xref>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB2">II</xref>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
We successfully genotyped 173 PCOS patients and 194 healthy control subjects for 32 SNPs (Table II) within 82 kb of the FBN3 gene region (gene map in Fig. 1). We included SNPs (n = 10) that result in non-synonymous amino acid changes in the FBN3 protein (Table II), with the intention of identifying PCOS-associated FBN3 mutations that might lead to defects in the functioning of the FBN3 protein either pre- or post-translationally. One SNP (rs17202741) showed no heterogeneity in the population and another (rs12972954) showed significant departures from Hardy-Weinberg equilibrium (possibly indicating a problem with the primers used for genotyping). Both were subsequently excluded from further analyses.
###end p 27
###begin p 28
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 151 153 151 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 366 367 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 429 434 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL25</italic>
###xml 439 443 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
Unphased association analysis for 30 SNPs all of which can be mapped within an 82 kb region spanning FBN3. Chromosomal position is plotted versus -log P-value for chi-square tests of association of each marker with PCOS. The dotted lines represent the cut-off mark for P-values reaching significance before Bonferroni's correction for multiple testing (P</=0.05 and P</=0.01). The position of introns and exons of the two genes (CCL25 and FBN3) relative to the SNPs analysed are displayed below the graph. Markers are 1 rs2287936, 2 rs10424096, 3 rs17261710, 4 rs2303169, 5 rs17160147, 6 rs12151028, 7 rs7245429, 8 rs7245552, 9 rs12608849, 10 rs12150963, 11 rs3829817, 12 rs3865464, 13 rs33967815, 14 rs10445638, 15 rs3813779, 16 rs8111335, 17 rs12975322, 18 rs4804063, 19 rs2086149, 20 rs35579498, 21 rs4527136, 22 rs35840170, 23 rs3813774, 24 rs12974280, 25 rs8112525, 26 rs2061776, 27 rs7246376, 28 rs12162237, 29 rs7252584 and 30 rs7256533.
###end p 28
###begin p 29
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
Information on the SNPs examined, including chromosomal and gene location, sequence variation and the frequencies of their minor alleles for both control and PCOS patients, and the P-value for deviation of the genotype frequencies from the Hardy-Weinberg equilibrium
###end p 29
###begin p 30
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aReference SNP cluster identification number.
###end p 30
###begin p 31
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 84 103 84 103 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="www.genome.ucsc.edu">www.genome.ucsc.edu</uri>
###xml 60 65 <span type="species:ncbi:9606">human</span>
bPosition of nucleotide on chromosome 19 in Build 35 of the human genome from UCSC (www.genome.ucsc.edu).
###end p 31
###begin p 32
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
cP-value for deviation of genotype frequencies from Hardy-Weinberg equilibrium.
###end p 32
###begin p 33
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
dMinor allelic frequency calculated using Haploview software.
###end p 33
###begin p 34
###xml 0 6 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
daggerSNP displaying significant departure from Hardy-Weinberg equilibrium.
###end p 34
###begin p 35
###xml 0 12 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;&#8224;</sup>
daggerdaggerPotential SNP found not to be allelic. # The bases listed are those used in our design of primers and may represent the complimentary bases as listed in the Public Id.
###end p 35
###begin title 36
SNP association analyses
###end title 36
###begin p 37
###xml 71 74 71 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB3">III</xref>
###xml 338 353 338 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C12">Dudbridge, 2008</xref>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F1">1</xref>
###xml 549 554 549 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 541 561 541 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C4">Barrett <italic>et al</italic>., 2005</xref>
###xml 618 619 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 669 672 669 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB3">III</xref>
###xml 730 731 730 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The results of the Sequenom genotyping analysis are displayed in Table III. Relative frequencies for each allele of the 30 SNPs analysed from PCOS and control subjects are summarized. Most alleles showed almost identical population frequencies between PCOS and control subjects. SNP association analyses performed with unphased software (Dudbridge, 2008) found only one SNP (rs3813774) that achieved a significant (P = 0.04 uncorrected) association with PCOS (Fig. 1). In addition, case-control association analysis with Haploview software (Barrett et al., 2005) found one SNP (rs3813774) that achieved a significant (P = 0.04 uncorrected) association with PCOS (Table III). Upon correction for multiple comparisons, however, the P-value for this SNP no longer reached significance.
###end p 37
###begin p 38
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Association analysis of SNPs within the FBN3 gene with PCOS showing chromosomal position, chi-square values, P-values, odds ratios, confidence limits and allelic frequencies for each SNP
###end p 38
###begin p 39
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aReference SNP cluster ID.
###end p 39
###begin p 40
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 84 103 84 103 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="www.genome.ucsc.edu">www.genome.ucsc.edu</uri>
###xml 60 65 <span type="species:ncbi:9606">human</span>
bPosition of nucleotide on chromosome 19 in Build 35 of the human genome from UCSC (www.genome.ucsc.edu).
###end p 40
###begin p 41
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cChi-squared values calculated using unphased 3.0.10 software.
###end p 41
###begin p 42
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
dP-value of odds ratio.
###end p 42
###begin p 43
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
eOdds ratios were calculated using unphased 3.0.10 software.
###end p 43
###begin p 44
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sup>
fLower bound on the 95% confidence interval for the odds ratio.
###end p 44
###begin p 45
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</sup>
gUpper bound on the 95% confidence interval for the odds ratio.
###end p 45
###begin p 46
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
hP-value corrected for multiple testing (Bonferroni correction).
###end p 46
###begin p 47
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sup>
iNumber of alleles in control subjects.
###end p 47
###begin p 48
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</sup>
jNumber of alleles in case subjects.
###end p 48
###begin title 49
Haplotype association and linkage analyses
###end title 49
###begin p 50
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 174 194 174 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C4">Barrett <italic>et al</italic>., 2005</xref>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 501 521 501 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C14">Gabriel <italic>et al</italic>. (2002</xref>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F2">2</xref>
###xml 606 607 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F2">2</xref>
###xml 810 814 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 883 884 883 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F2">2</xref>
###xml 897 902 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 889 909 889 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>
In order to increase the potential to identify a PCOS-associated SNP in the FBN3 genomic region we also performed LD haplotype association analyses using Haploview software (Barrett et al., 2005). Haplotype association analysis can increase power to detect a signal from other unknown SNPs (not in current databases) by performing the association test on haplotype groups rather than individual SNPs. Four haplotype blocks with 18 haplotypes were identified by Haploview using the method described by Gabriel et al. (2002) (Fig. 2a). Haplotype association frequencies, haplotype population frequencies and D' scores of these haplotype blocks are shown in Fig. 2. Haplotype analysis failed to identify haplotypes that show significant association with PCOS. Given that the marker that led us to examine SNPs in FBN3 (the microsatellite D19S884) is located in a region of low LD (Fig. 2 and Urbanek et al., 2007), this result is perhaps not surprising as haplotype blocks do not by definition exist in regions of low LD.
###end p 50
###begin p 51
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 406 433 406 433 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.genome.ucsc.edu/">http://www.genome.ucsc.edu/</uri>
###xml 437 438 437 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 702 703 702 703 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 763 764 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1000 1001 998 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1047 1048 1043 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
(A) Haplotypes predicted by Haploview. Four blocks were observed with the haplotpes of each block shown. Darker lines between haplotypes indicate a higher percentage of association with the linked haplotypes. Haplotype frequencies are indicated in red. D' values for LD are indicated below each haplotype block. Chromosomal positions were taken from those reported for build 35 of the UCSC genome website (http://www.genome.ucsc.edu/). (B) Haploview generated graphic analysis of LD in an 82 kb region of chromosome 19 spanning FBN3. The relative position of each of the 31 markers (30 SNPs and D19S884, which is indicated with an arrow) on chromosome 19p13.2 is indicated by the vertical lines on the chromosomal map (top) and the proportion of LD (displayed as D'/LOD) is displayed below each marker. Haplotype blocks are indicated by dark lines. Strong LD (D' = 1, LOD >/= 2) is indicated by red, lighter shades pink indicate varying degrees of LD with lighter shades displaying less than darker (D' < 1, LOD >/= 2) and white indicates low LD (D' < 1, LOD < 2).
###end p 51
###begin title 52
Microsatellite D19S884 association analysis
###end title 52
###begin p 53
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB4">IV</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB4">IV</xref>
###xml 132 139 <span type="species:ncbi:9606">patient</span>
As we were unable to demonstrate association between the SNPs that we typed in the FBN3 region and PCOS, we decided to genotype our patient-control cohort for the previously associated microsatellite marker D19S884. Microsatellite D19S884 allele frequencies for the study group are shown in Table IV. The numbers of CA repeats ranged from 14 to 24 in our cohort, and repeats of 22, 17, 18 and 20 were the most common at 26-27, 17, 12-13 and 11%, respectively. The frequencies of each allele reported here are similar to those published previously (Table IV).
###end p 53
###begin p 54
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 263 283 263 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C46">Urbanek <italic>et al</italic>., 2005</xref>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 360 383 360 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C49">Villuendas <italic>et al</italic>., 2003</xref>
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
For each allele in microsatellite D19S884 this table lists information on the sizes of the amplicons using either the current primers or those for amplimer AFMa299zc5, the numbers of CA repeats, the identification numbers ascribed to alleles by a previous study (Urbanek et al., 2005), the frequencies of each allele listed in Genbank and in a previous study (Villuendas et al., 2003) and that obtained in the current experiment, and the P-value for association of an allele with PCOS calculated using Fisher's exact test
###end p 54
###begin p 55
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB1">I</xref>
*To detect microsatellite D19S884 we designed different primers (Table I) to that of amplimer AFMa299zc5 listed in Genbank, hence the current amplicons differ in size.
###end p 55
###begin p 56
###xml 0 6 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
daggerFrequencies of alleles listed in Genbank are from 8 CEPH families composed of 56 individuals as described for the microsatellite polymorphism rs3222751 under reference submission ss4914553.
###end p 56
###begin p 57
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
aP-value for association of a microsatellite allele with PCOS calculated by Fisher's exact test.
###end p 57
###begin p 58
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bLower bound on the 95% confidence interval for the odds ratio.
###end p 58
###begin p 59
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cUpper bound on the 95% confidence interval for the odds ratio.
###end p 59
###begin p 60
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
dP-value corrected for multiple testing (Bonferroni correction).
###end p 60
###begin p 61
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 398 399 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="GAP072TB4">IV</xref>
Microsatellite allele association analyses were performed using Fisher's exact test and the Clump program. Fisher's exact test did not identify any alleles of D19S884 that were significantly associated with PCOS. Allele 10 (19 CA repeats) was the only allele that was significant (P = 0.04 uncorrected), however, upon correction for multiple testing this P-value no longer approached significance (P = 0.52) (Table IV). Clump analysis of D19S884 failed to identify association between any of the 11 alleles detected and PCOS (data not shown).
###end p 61
###begin title 62
###xml 27 32 <span type="species:ncbi:9606">human</span>
FBN and LTBP expression in human ovaries
###end title 62
###begin p 63
###xml 30 43 30 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1, 2 and 3</italic>
###xml 50 51 50 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F3">3</xref>
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 69 71 69 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-2</italic>
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F4">4</xref>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F3">3</xref>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F3">3</xref>
###xml 680 684 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 733 734 733 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F3">3</xref>
###xml 794 798 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 803 804 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 881 882 881 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F3">3</xref>
###xml 96 101 <span type="species:ncbi:9606">human</span>
We examined the expression of FBN1, 2 and 3 (Fig. 3), and LTBP-1 and -2 mRNA (Fig. 4) in normal human ovarian tissues including stroma/cortex (n = 9 non-PCO and 4 PCO ovarian phenotype), follicles (n = 3) and corpora lutea (n = 3) and ovarian cell lines. Expression levels for each gene were not significantly different between stroma, follicles and corpora lutea. FBN1 mRNA levels were 50-100 times greater than FBN2 and 200-1000-fold higher than FBN3 (Fig. 3). The granulosa tumour cell line KGN displayed similar levels of FBN1 and 2 but lower levels of FBN3 expression when compared with normal ovarian tissue samples (Fig. 3). OVCAR-3, OVCAR-5 and SKOV-3 had lower levels of FBN1 than normal ovarian tissues and KGN cells (Fig. 3). OVCAR-3 cells had very high levels of expression of both FBN2 and 3 expression compared with the other cell lines and the ovarian tissues (Fig. 3).
###end p 63
###begin p 64
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 20 21 20 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 30 31 30 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 250 251 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
Expression of FBN1 (A), FBN2 (B) and FBN3 (C) mRNA in human ovarian tissues and from the human ovarian tumour cell lines KGN, OVCAR-3, OVCAR-5 and SKOV-3. Data are presented as the mean values +/- SEM expressed as fmoles RNA/nmole 18S ribosomal RNA, n = 4, 9, 3 and 3 for the PCO stroma/cortex and non-PCO stroma/cortex, follicles and corpora lutea (CL), respectively.
###end p 64
###begin p 65
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 22 23 22 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-2</italic>
###xml 37 38 37 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 244 245 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
Expression of LTBP-1 (A) and LTBP-2 (B) mRNA in human ovarian tissues and from the human ovarian tumour cell lines KGN, OVCAR-3, OVCAR-5 and SKOV-3. Data are presented as the mean values +/- SEM expressed as fmoles RNA/nmole 18S ribosomal RNA, n = 4, 9, 3 and 3 for the PCO stroma/cortex and non-PCO stroma/cortex, follicles and corpora lutea (CL), respectively.
###end p 65
###begin p 66
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-2</italic>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F4">4</xref>
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-2</italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F4">4</xref>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 408 412 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BP-1</italic>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="GAP072F5">5</xref>
LTBP-1 expression levels were >3-fold greater than LTBP-2 in normal ovarian tissues (Fig. 4). OVCAR-3, OVCAR-5 and SKOV-3 had lower levels of LTBP-2 than normal ovarian tissues, but LTBP-1 expression was variable across the cell lines; with OVCAR-3 having the highest levels of expression (Fig. 4). Correlation analyses were conducted and FBN1 expression significantly correlated with FBN2 (P < 0.001) and LTBP-1 (P < 0.01) and FBN2 with LTBP-1 (P < 0.001) across all tissues (Fig. 5).
###end p 66
###begin p 67
###xml 18 19 18 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 144 149 <span type="species:ncbi:9606">human</span>
Scatter plots of (A) FBN2 versus FBN1, (B) LTBP-1 versus FBN1 and (C) LTBP-1 versus FBN2 mRNA expression (fmoles/nmole 18S ribosomal RNA) using human ovarian tissues (excluding cell lines; n = 19). The P-values and correlation coefficient (R) relate to correlation with a Pearson's two-tailed test.
###end p 67
###begin title 68
Discussion
###end title 68
###begin p 69
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN</italic>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP</italic>
###xml 426 432 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 437 439 437 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-2</italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
We have conducted a case-control study of PCOS examining the genotypes of 30 SNPs, including 10 functional SNPs, in an 82 kb region of chromosome 19 flanking FBN3. In our cohort, we also genotyped the microsatellite marker D19S884, previously reported to be associated with PCOS by familial linkage analyses and located within intron 55 of FBN3. In addition, we examined the expression of the three FBNs and two of the LTBPs (LTBP-1 and -2) in ovarian tissues. We conclude that if FBN3 is involved in the aetiology of PCOS then its role is not readily apparent from these studies.
###end p 69
###begin p 70
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 251 252 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 252 253 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 533 541 <span type="species:ncbi:9606">patients</span>
Tagging SNPs were chosen to span an 82 kb region of the FBN3 gene, which flanks the previously associated microsatellite marker D19S884, such that approximately100% of SNP alleles with minor allele frequencies >5% in this region were captured with an r2 value of >0.8. Thus, we would have expected to have been able to identify any common SNP within this region of 19p13.2 that showed significant association with PCOS. None of the 30 SNPs we tested had allele frequencies that were significantly different between controls and PCOS patients once corrected for multiple testing.
###end p 70
###begin p 71
###xml 711 716 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 703 723 703 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>
###xml 1054 1058 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 1301 1306 1301 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1295 1313 1295 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>
###xml 1323 1328 1323 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1315 1335 1315 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>
Microsatellite D19S884 is located in a non-conserved intronic region that displays low levels of LD, thus it remains possible that a causal SNP is located within this region. The closest SNP markers to D19S884 (chromosomal position 8056140) that were analysed here were rs17160147 and rs1251028, which are located at 2098 bp 3' and 8784 bp 5' of D19S884, respectively. There is at least one other SNP (rs1246064) in this region that was not analysed, nor captured by our tagging SNPs, and is heterogeneous in the CEU population. It is, however, unlikely that this SNP is causal for PCOS as it does not result in changes to protein sequence and was not found to be associated with PCOS in another study (Urbanek et al., 2007). There are other SNPs in this region that are heterogeneous in either African (rs8102892, rs8112982), Asian (rs8105886, rs17160153) or both populations (rs17160151, rs12984611) but these are not heterogeneous in a European population and hence unlikely to be causal in an Australian population. As we did not find any SNP in the FBN3 gene region that showed any significant association with PCOS, we examined the association of the microsatellite marker D19S884 in our cohort. Previous studies identified allele 8 (17 CA di-nucleotide repeats) as segregating with PCOS (Tucci et al., 2001; Urbanek et al., 2007). However, we were unable to identify any allele of the microsatellite that showed any significant association with PCOS in our cohort, after correcting for multiple testing.
###end p 71
###begin p 72
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 137 155 137 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 157 177 157 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 302 320 302 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 366 386 366 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>
###xml 985 990 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 979 997 979 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>
###xml 1010 1015 1010 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 999 1022 999 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C49">Villuendas <italic>et al</italic>., 2003</xref>
The results presented here would appear to be in disagreement with other studies that found strong association between D19S884 and PCOS (Tucci et al., 2001; Urbanek et al., 2007). Both studies were conducted on subjects recruited solely from the USA and who fulfilled the 1990 NIH criteria. One study (Tucci et al., 2001) was a case-control study whereas the other (Urbanek et al., 2007) was a family-based study. We also recruited subjects of Caucasian background from the Australian population who fulfilled the 1990 NIH criteria for a case-control study. It is possible but unlikely that there are differences in genetic background with regard to PCOS between the Australian population and that of the USA. While the number of subjects in our study is low, our power calculations suggest that we had enough power to detect mutations that have a moderate (0.3) effect size and our numbers are much higher (173/194 PCOS/control subjects) than two previous case-control studies (Tucci et al., 2001; Villuendas et al., 2003) having 85/87 and 108/66 PCOS/control subjects, respectively. Our study is therefore more likely to be reflective of population allele frequencies and less prone to sampling bias. Despite this, it is possible that our numbers were too low to detect association of D19S884 with PCOS in the Australian population.
###end p 72
###begin p 73
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1, 2</italic>
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 47 49 47 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-2</italic>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 394 398 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 561 582 561 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 781 802 781 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>
###xml 858 864 858 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 978 983 978 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 969 990 969 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>
###xml 1030 1036 1030 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 1156 1161 1156 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1147 1168 1147 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>
###xml 1219 1223 1219 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 1228 1234 1228 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 1414 1419 1414 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1407 1426 1407 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C23">Isogai <italic>et al</italic>., 2003</xref>
###xml 1443 1447 1443 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 1452 1453 1452 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 1458 1464 1458 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 1591 1594 1591 1594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN</italic>
###xml 1617 1623 1617 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-2</italic>
###xml 1632 1638 1632 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 1649 1654 1649 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1640 1661 1640 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>
###xml 521 527 <span type="species:ncbi:9913">bovine</span>
###xml 629 635 <span type="species:ncbi:9913">bovine</span>
###xml 929 935 <span type="species:ncbi:9913">bovine</span>
###xml 996 1002 <span type="species:ncbi:9913">bovine</span>
###xml 1538 1544 <span type="species:ncbi:9913">bovine</span>
###xml 1757 1763 <span type="species:ncbi:9606">humans</span>
###xml 1775 1781 <span type="species:ncbi:9913">bovine</span>
The expression of FBN1, 2 and 3 and LTBP-1 and -2 were examined in PCO ovarian stroma/cortex and non-PCO stroma/cortex, follicles and corpora lutea and clear patterns emerged. Firstly, there were no differences between stroma from ovaries with a PCO phenotype and those from non-PCO ovaries in any of the genes examined. In all the tissues examined, the expression of FBN1 was far greater than FBN2, which was far greater than FBN3, which was barely detectible. A similar pattern of expression was previously observed in bovine tunica and stroma of the cortex (Prodoehl et al., 2009). In our previous study, we found that in the bovine ovary, the expression of FBN1 within follicles was confined to the theca interna and in the tunica and stroma (corpora lutea were not examined) (Prodoehl et al., 2009). In the current study we found that the expression of LTBP-1 was greater than that of LTBP-2, which was also observed in the bovine tunica and stroma of the cortex (Prodoehl et al., 2009). In bovine ovaries, the expression of LTBP-1 was localized to the tunica and stroma of the cortex and in follicles in the inner area of the theca externa (Prodoehl et al., 2009). Additionally, the immunolocalization pattern of FBN1 and LTBP-1 were fibrillar in the tunica and stroma of the cortex and in the thecal layers, suggesting that they are both associated with microfibrils as has been observed previously (Isogai et al., 2003). Expression of FBN1 and 2 and LTBP-1 in the ovarian tissues examined here were correlated with each other. In bovine tunica and cortical stromal samples all three FBNs were correlated with LTBP-2 and not LTBP-1 (Prodoehl et al., 2009). This suggests that there is some degree of coordinate regulation amongst these genes in both humans and in the bovine.
###end p 73
###begin p 74
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 268 286 268 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C36">Nishi <italic>et al</italic>., 2001</xref>
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1, 2</italic>
###xml 326 327 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 332 338 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 561 563 561 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-2</italic>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 648 669 648 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>
###xml 712 716 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN2</italic>
###xml 718 719 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 725 731 725 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTBP-1</italic>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 571 577 <span type="species:ncbi:9913">bovine</span>
To increase our knowledge of fibrillin family members in ovaries expression was also examined in human ovarian cancer cell lines OVCAR-3, OVCAR-5 and SKOV-3 (ascites derived) derived from ovarian adenocarcinoma, and in KGN cells which have a granulosa cell phenotype (Nishi et al., 2001). The expression levels of FBN1, 2 and 3 and LTBP-1 in the KGN cells was generally similar to that of the other ovarian tissues examined. The expression of these genes was much lower in the OVCAR-5 and SKOV-3 cells, in agreement with the localization of FBN1 and LTBP-1 and -2 in the bovine where no localization to the ovarian surface epithelium was observed (Prodoehl et al., 2009). However, OVCAR-3 had elevated levels of FBN2, 3, and LTBP-1 relative to normal ovarian tissues and other ovarian cancer cell lines.
###end p 74
###begin p 75
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 815 819 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN3</italic>
###xml 363 368 <span type="species:ncbi:9606">human</span>
It appears, from our genetic analysis, that the marker D19S884 and its associated gene, FBN3, have little or no impact on PCOS pathology in the Australian population. We cannot, however, rule out the possibility that other markers in the region of chromosome 19p13.2 are associated. Additionally our study of expression of five members of the fibrillin family in human ovaries found very low levels of FBN3, but our study also cannot rule out that alterations in FBN3 expression occur in other organs or tissues such as the anterior pituitary, influencing hormonal regulation of the ovary or adipose tissue. It is also possible that a genetic lesion in the FBN3 gene associated with PCOS pathology may cause functional changes in the protein's structure without affecting its expression levels. We conclude that if FBN3 is involved in the aetiology of PCOS then its role is not readily apparent from these studies.
###end p 75
###begin title 76
Authors' Role
###end title 76
###begin p 77
###xml 335 343 <span type="species:ncbi:9606">patients</span>
###xml 394 402 <span type="species:ncbi:9606">patients</span>
###xml 468 473 <span type="species:ncbi:9606">human</span>
M.J.P., N.H., H.F.I.-R., M.A.G. and R.J.R. planned the experiments, conducted RT-PCR, microsatellite analyses, statistical analysis and wrote the manuscript. Z.Z.Z., J.N.P. and G.W.M. conducted the SNP analysis and statistical analysis and assisted in writing the manuscript. T.E.H. and R.J.N. developed the cohort of PCOS and control patients, isolated the DNA from the lymphocytes from these patients, and reviewed the manuscript. W.E.R., B.R.C. and H.D.M. provided human ovarian samples and RNA and reviewed the manuscript.
###end p 77
###begin title 78
Funding
###end title 78
###begin p 79
###xml 55 112 55 112 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Health and Medical Research Council of Australia</funding-source>
###xml 138 178 138 178 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">the Clive and Vera Ramaciotti Foundation</funding-source>
###xml 180 198 180 198 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">the Wellcome Trust</funding-source>
###xml 204 232 204 232 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institute of Health</funding-source>
###xml 238 265 238 265 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Medical Research Council UK</funding-source>
Funding to support this research was obtained from the National Health and Medical Research Council of Australia, University of Adelaide, the Clive and Vera Ramaciotti Foundation, the Wellcome Trust, and National Institute of Health, and Medical Research Council UK.
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
###xml 160 164 <span type="species:ncbi:4530">Rice</span>
We thank Professors Hajime Nawata and Toshihiko Yanase of Kyushu University and Professor Yoshihiro Nishi of Kurume University for the KGN cell line, Drs Suman Rice and Laura Pellatt for ovarian tissues, and Dr Carmela Ricciardelli and Miranda Ween for the cancer cell lines. Funding to pay the Open Access publication charges for this article was provided by the National Health and Medical Research Council of Australia.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
###xml 36 41 <span type="species:ncbi:9606">women</span>
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
###end article-title 83
###begin article-title 84
The genetics of polycystic ovary syndrome
###end article-title 84
###begin article-title 85
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients
###end article-title 85
###begin article-title 86
Haploview: analysis visualization of LD haplotype maps
###end article-title 86
###begin article-title 87
Molecular genetics of Marfan syndrome
###end article-title 87
###begin article-title 88
Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
###end article-title 88
###begin article-title 89
Extracellular matrix containing mutated fibrillin-1 (Fbn1) down regulates Col1a1, Col1a2, Col3a1, Col5a1, and Col5a2 mRNA levels in Tsk/+ and Tsk/Tsk embryonic fibroblasts
###end article-title 89
###begin article-title 90
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients
###end article-title 90
###begin article-title 91
###xml 70 75 <span type="species:ncbi:9606">human</span>
Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues
###end article-title 91
###begin article-title 92
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile
###end article-title 92
###begin article-title 93
Likelihood-for nuclear families and unrelated subjects with missing genotype data
###end article-title 93
###begin article-title 94
Polycystic ovary syndrome
###end article-title 94
###begin article-title 95
###xml 41 46 <span type="species:ncbi:9606">human</span>
The structure of haplotype blocks in the human genome
###end article-title 95
###begin article-title 96
Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism
###end article-title 96
###begin article-title 97
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils
###end article-title 97
###begin article-title 98
Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-beta binding proteins
###end article-title 98
###begin article-title 99
###xml 128 134 <span type="species:ncbi:9913">bovine</span>
Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?
###end article-title 99
###begin article-title 100
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid
###end article-title 100
###begin article-title 101
Genealogy expression cellular function of transforming growth factor-beta
###end article-title 101
###begin article-title 102
LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 competes with LTBP-1 for binding to this microfibrillar protein
###end article-title 102
###begin article-title 103
Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis"
###end article-title 103
###begin article-title 104
Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein
###end article-title 104
###begin article-title 105
Polymorphism of the follistatin gene in polycystic ovary syndrome
###end article-title 105
###begin article-title 106
TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences
###end article-title 106
###begin article-title 107
###xml 138 146 <span type="species:ncbi:9606">patients</span>
A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients
###end article-title 107
###begin article-title 108
Elastic fibres
###end article-title 108
###begin article-title 109
###xml 74 79 <span type="species:ncbi:9606">women</span>
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study
###end article-title 109
###begin article-title 110
Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes
###end article-title 110
###begin article-title 111
###xml 37 42 <span type="species:ncbi:9606">women</span>
Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity
###end article-title 111
###begin article-title 112
Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid
###end article-title 112
###begin article-title 113
No association between the -308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries
###end article-title 113
###begin article-title 114
A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1
###end article-title 114
###begin article-title 115
Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein
###end article-title 115
###begin article-title 116
Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome
###end article-title 116
###begin article-title 117
###xml 54 59 <span type="species:ncbi:9606">human</span>
Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor
###end article-title 117
###begin article-title 118
###xml 50 56 <span type="species:ncbi:9913">bovine</span>
Fibrillins and latent TGFbeta binding proteins in bovine ovaries of offspring following high or low protein diets during pregnancy of dams
###end article-title 118
###begin article-title 119
The fibrillins
###end article-title 119
###begin article-title 120
Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils
###end article-title 120
###begin article-title 121
###xml 92 97 <span type="species:ncbi:9606">women</span>
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome
###end article-title 121
###begin article-title 122
###xml 39 44 <span type="species:ncbi:9606">women</span>
Coronary heart disease risk factors in women with polycystic ovary syndrome
###end article-title 122
###begin article-title 123
The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding
###end article-title 123
###begin article-title 124
###xml 67 72 <span type="species:ncbi:9606">women</span>
Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus
###end article-title 124
###begin article-title 125
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin
###end article-title 125
###begin article-title 126
Allelic variants of the follistatin gene in polycystic ovary syndrome
###end article-title 126
###begin article-title 127
Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2
###end article-title 127
###begin article-title 128
Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype
###end article-title 128
###begin article-title 129
TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression
###end article-title 129
###begin article-title 130
Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome
###end article-title 130
###begin article-title 131
Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy
###end article-title 131
###begin article-title 132
Database resources of the National Center for Biotechnology
###end article-title 132
###begin article-title 133
###xml 54 62 <span type="species:ncbi:9606">patients</span>
The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome
###end article-title 133
###begin article-title 134
###xml 60 65 <span type="species:ncbi:9606">women</span>
Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome
###end article-title 134
###begin article-title 135
###xml 50 55 <span type="species:ncbi:9606">women</span>
Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance
###end article-title 135
###begin article-title 136
###xml 92 97 <span type="species:ncbi:9606">women</span>
Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome
###end article-title 136
###begin article-title 137
Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3)
###end article-title 137
###begin article-title 138
Diagnostic criteria for polycystic ovary syndrome: towards a rational approach
###end article-title 138
###begin article-title 139
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models
###end article-title 139
###begin article-title 140
KRAS variation and risk of endometriosis
###end article-title 140

